Synthesis and biological evaluation of L-cysteine derivatives as mitotic kinesin Eg5 inhibitors

被引:50
|
作者
Ogo, Naohisa
Oishi, Shinya
Matsuno, Kenji
Sawada, Jun-ichi
Fujii, Nobutaka
Asai, Akira
机构
[1] Univ Shizuoka, Sch Pharmaceut Sci, Ctr Drug Discovery, Shizuoka 422, Japan
[2] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 606, Japan
关键词
S-trityl-L-cysteine; mitotic kinesin; Eg5; inhibitor; anticancer;
D O I
10.1016/j.bmcl.2007.04.101
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Inhibition of Eg5 represents a novel approach for the treatment of cancer. Here, we report the synthesis and structure-activity relationship of S-trityl-L-cysteine (STLC) derivatives as Eg5 inhibitors. Some of these derivatives such as 4f demonstrated enhanced inhibitory activity against Eg5 and induced mitotic arrest with characteristic monoastral spindles in HeLa cells. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3921 / 3924
页数:4
相关论文
共 50 条
  • [11] Mechanistic analysis of the mitotic kinesin Eg5
    Cochran, JC
    Sontag, CA
    Maliga, Z
    Kapoor, TM
    Correia, JJ
    Gilbert, SP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (37) : 38861 - 38870
  • [12] Structure-activity relationship of S-trityl-L-cysteine analogues as inhibitors of the human mitotic kinesin Eg5
    DeBonis, Salvatore
    Skoufias, Dimitrios A.
    Indorato, Rose-Laure
    Liger, Francois
    Marquet, Bernard
    Laggner, Christian
    Joseph, Benoit
    Kozielski, Frank
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (05) : 1115 - 1125
  • [13] Structural Kinetics of the Mitotic Kinesin Eg5
    Muretta, Joseph
    Parks, William Behnke
    Petersen, Karl
    Goulet, Adeline
    Moores, Carolyn
    Thomas, David D.
    Rosenfeld, Steven
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 779A - 779A
  • [14] Screening of Novel Mitotic Kinesin Eg5 Inhibitors in Human Cancer Cells
    Watanabe, M.
    Serizawa, M.
    Suzuki, J.
    Ogo, N.
    Yamamoto, N.
    Koh, Y.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 39 - 39
  • [15] Single Molecule Analysis of the Mitotic Kinesin Eg5
    Weinger, Joshua S.
    Kapoor, Tarun M.
    BIOPHYSICAL JOURNAL, 2010, 98 (03) : 165A - 165A
  • [16] Morelloflavone as a novel inhibitor of mitotic kinesin Eg5
    Ogunwa, Tomisin Happy
    Taii, Kenichi
    Sadakane, Kei
    Kawata, Yuka
    Maruta, Shinsaku
    Miyanishi, Takayuki
    JOURNAL OF BIOCHEMISTRY, 2019, 166 (02): : 129 - 137
  • [17] Mechanistic analysis of human mitotic kinesin, Eg5
    Cochran, JC
    Sontag, CA
    Correia, JJ
    Maliga, Z
    Kapoor, TM
    Mitchison, TJ
    Gilbert, SP
    BIOPHYSICAL JOURNAL, 2003, 84 (02) : 444A - 444A
  • [18] Validation of the mitotic kinesin Eg5 as a therapeutic target in leukemia using S-trityl-L-cysteine
    Wang, L. S.
    Ren, W. H.
    ShangGuan, Z. M.
    Liang, X. L.
    WanYan, X. J.
    Wang, B. L.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2012, 22 (04) : 285 - 289
  • [19] Loop L5 Acts as a Conformational Latch in the Mitotic Kinesin Eg5
    Behnke-Parks, William M.
    Vendome, Jeremie
    Honig, Barry
    Maliga, Zoltan
    Moores, Carolyn
    Rosenfeld, Steven S.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (07) : 5242 - 5253
  • [20] Loop L5 Acts as a Conformational Latch in the Mitotic Kinesin Eg5
    Behnke-Parks, William M.
    Vendome, Jeremie
    Maliga, Zoltan
    Moores, Carolyn
    Rosenfeld, Steven
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 530 - 530